[{"data":1,"prerenderedAt":66},["ShallowReactive",2],{"q-nurse-109-2-basic-medicine-023":3},{"subject":4,"subjectSlug":5,"subjectFullName":6,"question":7,"related":37,"lastmod":65},"基礎醫學","basic-medicine","基礎醫學(包括解剖學、生理學、病理學、藥理學、微生物學與免疫學)",{"id":8,"webId":9,"year":10,"session":11,"subject":4,"number":12,"stem":13,"options":14,"answer":19,"answerNote":20,"images":21,"explanation":22,"explanationDeep":23,"topics":24,"freq":27},"nurse-109-2-基礎醫學-023","nurse-109-2-basic-medicine-023",109,2,23,"治療憂鬱症主要針對下列何種神經傳導物質進行調節？",{"A":15,"B":16,"C":17,"D":18},"GABA（γ-aminobutyric acid）","血清素（serotonin）","乙醯膽鹼（acetylcholine）","腎上腺素（epinephrine）","B",null,[],"本題考點是憂鬱症的神經傳導物質病理與藥物標的。依單胺假說,憂鬱症與腦內單胺類(尤其血清素,及正腎上腺素)功能低下有關,主流抗憂鬱藥如選擇性血清素回收抑制劑(SSRI)即透過提升突觸間隙血清素濃度來改善症狀,故正解B。A GABA是主要抑制性傳導物,為抗焦慮與抗癲癇藥標的,非憂鬱症主軸。C乙醯膽鹼與記憶認知、副交感功能及失智症相關,非抗憂鬱標的。D腎上腺素主要作用於周邊心血管與壓力反應,中樞情緒調節仍以血清素為主。故選血清素。","抗憂鬱藥分類與機轉:SSRI(fluoxetine)抑制血清素回收;SNRI(venlafaxine)兼抑血清素與正腎上腺素;TCA三環類廣抑回收但副作用多;MAOI抑制單胺氧化酶減少分解。單胺假說外亦有神經可塑性與BDNF假說,解釋藥效需2-4週才顯現(受體下調與神經新生)。SSRI併用其他血清素藥物須警覺血清素症候群(高熱、肌陣攣、意識改變)。記憶:憂鬱=「血清素不足」,SSRI補回。",[25,28,30,32,35],{"term":26,"count":27},"血清素",3,{"term":29,"count":27},"神經傳導物質",{"term":31,"count":11},"SSRI",{"term":33,"count":34},"單胺假說",1,{"term":36,"count":34},"憂鬱症藥理",[38,42,47,51,56,61],{"webId":39,"stem":40,"number":41,"year":10,"session":11},"nurse-109-2-basic-medicine-024","下列何種類型的病人，會有促腎上腺皮質素（ACTH）大量分泌的情況？",24,{"webId":43,"stem":44,"number":45,"year":46,"session":34},"nurse-110-1-basic-medicine-040","骨質疏鬆症（osteoporosis）與下列那一徵候較無關？",40,110,{"webId":48,"stem":49,"number":50,"year":46,"session":11},"nurse-110-2-basic-medicine-054","如果一個藥物的半衰期為 10 小時，以靜脈輸注此藥物後，在血液中達到穩定濃度所需的時間約多久？",54,{"webId":52,"stem":53,"number":54,"year":55,"session":34},"nurse-112-1-basic-medicine-042","補體活化路徑中所產生的膜攻擊複合體（membrane attack complex）包含了下列何者？",42,112,{"webId":57,"stem":58,"number":59,"year":60,"session":11},"nurse-113-2-basic-medicine-046","有關梅毒螺旋體（Treponema pallidum），下列敘述何者正確？",46,113,{"webId":62,"stem":63,"number":45,"year":64,"session":27},"nurse-114-3-basic-medicine-040","下列何者為人源性單株抗體（ humanized monoclonal antibody），用於免疫抑制誘導治療（induction immunosuppressant therapy）？",114,"2026-09-04",1788510714940]